| RPRX Stock | | | USD 25.85 0.15 0.58% |
Royalty Pharma financial indicator trend analysis is much more than just breaking down Royalty Pharma Plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Royalty Pharma Plc is a good investment. Please check the relationship between Royalty Pharma Other Current Assets and its Total Current Liabilities accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
Other Current Assets vs Total Current Liabilities
Other Current Assets vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Royalty Pharma Plc Other Current Assets account and
Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Royalty Pharma's Other Current Assets and Total Current Liabilities is 0.83. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Royalty Pharma Plc, assuming nothing else is changed. The correlation between historical values of Royalty Pharma's Other Current Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Royalty Pharma Plc are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Other Current Assets i.e., Royalty Pharma's Other Current Assets and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.83 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Total Current Liabilities
Total Current Liabilities is an item on Royalty Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Royalty Pharma Plc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Royalty Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Royalty Pharma Plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
At this time, Royalty Pharma's
Selling General Administrative is fairly stable compared to the past year.
Issuance Of Capital Stock is expected to grow at the current pace this year, whereas
Sales General And Administrative To Revenue is likely to drop 0.06 in 2024.
Royalty Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Royalty Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Royalty Pharma fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to
measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to
predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.